Prognostic significance of cell proliferation and apoptosis-regulating proteins in epstein-barr virus positive and negative pediatric non-hodgkin's lymphoma

Pathology and Oncology Research

Volumn 15, Issue 3, 2009, Pages 345-350

  Aktaş, Safiye ^a,c   Kargı, Aydanur ^a   Olgun, Nur ^a   Diniz, Gulden ^b   Erbay, Ayşe ^b   Vergin, Canan ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Dr Behcet Uz Children Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Apoptosis; Epstein Barr virus; Pediatric non Hodgkin's lymphoma; Prognosis; Proliferation

Indexed keywords

FAS ANTIGEN; KI 67 ANTIGEN; LATENT MEMBRANE PROTEIN 1; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SURVIVIN;

ADOLESCENT; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CHILDHOOD CANCER; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; EVENT FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; NONHODGKIN LYMPHOMA; NONHUMAN; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; SCORING SYSTEM; VIRUS CARCINOGENESIS;

EID: 73449138418     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9127-8     Document Type: Article

References (35)

1. NL Harris ES Jaffe J Diebold G Flandrin HK Muller-Hermelink J Vardiman TA Lister CD Bloomfield 2000 The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997 Hematol J 1 1 53 66 10.1038/sj.thj.6200013 1:STN:280:DC%2BD387oslCltg%3D%3D 11920170
2. KN Naresh B Agarwal BN Nathwani J Diebold KA McLennan KH Muller-Hermelink JO Armitage DD Weisenburger 2004 Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists Leuk Lymphoma 45 8 1569 1577 10.1080/10428190410001683679 15370208 (Pubitemid 38885999)
3. MS Cairo R Sposto SL Perkins AT Meadows ML Hoover-Regan JR Anderson SE Siegel MA Lones N Tedeschi-Blok ME Kadin CR Kjeldsberg JF Wilson W Sanger E Morris MD Krailo JL Finlay 2003 Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience Br J Haematol 120 4 660 670 10.1046/j.1365-2141.2003.04134.x 12588354 (Pubitemid 36255868)
4. H Campe G Jaeger C Abou-Ajram H Nitschko M Griebel C Montoya B Klare U Koszinowski 2003 Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease Pediatr Transplant 7 1 46 52 10.1034/j.1399-3046.2003.02051.x 1:CAS:528:DC%2BD3sXjtlygtbw%3D 12581328 (Pubitemid 36314190)
5. KCM Straathof CM Bollard CM Rooney HE Heshlop 2003 Immunotherapy for Epstein-Barr-Virus associated cancers in children The Oncologist 8 83 98 10.1634/theoncologist.8-1-83 1:CAS:528:DC%2BD3sXhvVyqtr0%3D 12604735 (Pubitemid 36232359)
6. MV Preciado A Fallo P Chabay L Calcagno E De Matteo 2002 Epstein Barr virus-associated lymphoma in HIV-infected children Pathol Res Pract 198 5 327 332 10.1078/0344-0338-5710262 12092768
7. E Cabalo R Wilkinson NT Lu S Shimizu M Melish KL McClain HB Jenson B Shiramizu 2002 Molecular analysis and pathology of a second pediatric HIV-associated Burkitt lymphoma Pediatr Pathol Mol Med 21 6 525 530 10.1080/15227950290112770 12537769 (Pubitemid 35423740)
8. CR Rao MI Gutierrez K Bhatia F Fend J Franklin L Appaji G Gallo G O'Conor N Lalitha I Magrath 2000 Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries Leuk Lymphoma 39 3-4 329 337 1:STN:280:DC%2BD3Mrjs12nuw%3D%3D 11342313
9. I Araujo HD Foss A Bittencourt M Hummel G Demel N Mendonca H Herbst H Stein 1996 Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil Blood 87 12 5279 5286 1:CAS:528:DyaK28XjsFGitL0%3D 8652843
10. PA Chabay EN De Matteo L Aversa S Maglio S Grinstein MV Preciado 2002 Assessment of Epstein-Barr virus association with pediatric non-Hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina Arch Pathol Lab Med 126 3 331 335 11860309
11. N Tacyildiz AO Cavdar U Ertem A Oksal L Kutluay O Uluoglu JC Lin 1998 Unusually high frequency of a 69-bp deletion within the carboxy terminus of the LMP-1 oncogene of Epstein-Barr virus detected in Burkitt's lymphoma of Turkish children Leukemia 12 11 1796 1805 10.1038/sj.leu.2401203 1:CAS:528: DyaK1cXnvFKqsrc%3D 9823956
12. U Ertem F Duru A Pamir N Tacyildiz A Dagdemir A Akcayoz O Uluoglu T Tezic 1996 Burkitt's lymphoma in 63 Turkish children diagnosed over a 10 year period Pediatr Hematol Oncol 13 2 123 134 10.3109/08880019609030802 1:STN:280:DyaK28zktFClsg%3D%3D 8721026
13. N Nakamura H Nakamine J Tamaru S Nakamura T Yoshino K Ohshima M Abe 2002 The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement Mod Pathol 15 7 771 776 10.1097/01.MP.0000019577.73786.64 12118116 (Pubitemid 34787314)
14. AD Wennborg E Altiok JP Moore I Ernberg G Klein 1991 Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines Eur J Cancer 27 12 1643 1645 10.1016/0277-5379(91)90436-H 1:CAS:528:DyaK38Xht1Gqs74%3D 1782076
15. CE Klumb R Hassan IR Zalcberg LM Resende MK Carrico RC Maia 2004 p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas Pediatr Blood Cancer 43 2 115 119 10.1002/pbc.20069 1:STN:280:DC%2BD2czjsVSktQ%3D%3D 15236276 (Pubitemid 38898718)
16. Y Hirose T Fukushima Y Masaki K Shimoyama H Karasawa N Ogawa Y Wano 2004 Epstein-Barr virus-associated composite lymphoma composed of peripheral T-cell lymphoma and an anaplastic variant of a diffuse large B-cell type of non-Hodgkin's lymphoma and strongly expressing p53 protein Int J Hematol 79 3 260 265 10.1532/IJH97.03156 1:CAS:528:DC%2BD2cXkvFCiurY%3D 15168595
17. S Camilleri-Broet P Camparo K Mokhtari KH Hoang-Xuan A Martin M Arborio JJ Hauw M Raphael 2000 Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients Mod Pathol 13 2 158 165 10.1038/modpathol.3880030 1:STN:280:DC%2BD3c7mtVentA%3D%3D 10697273
18. MI Gutierrez B Cherney A Hussain H Mostowski G Tosato I Magrath K Bhatia 1999 Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis Cancer Res 59 3 696 703 1:CAS:528: DyaK1MXhtFSjtbw%3D 9973220
19. T Faqing H Zhi Y Liqun T Min G Huanhua D Xiyun C Ya 2005 Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma Exp Oncol 27 2 96 101 15995625
20. A Martinez B Bellosillo F Bosch A Ferrer S Marce N Villamor G Ott E Montserrat E Campo D Colomer 2004 Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival Am J Pathol 164 2 501 510 1:CAS:528:DC%2BD2cXhsFGqsLw%3D 14742256
21. K Nakayama S Kamihira 2002 Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology Leuk Lymphoma 43 12 2249 2255 10.1080/1042819021000039956 1:CAS:528:DC%2BD3sXhtlOqsQ%3D%3D 12613509 (Pubitemid 35386146)
22. S Idenoue Y Hirohashi T Torigoe Y Sato Y Tamura H Hariu M Yamamoto T Kurotaki T Tsuruma H Asanuma T Kanaseki H Ikeda K Kashiwagi M Okazaki K Sasaki T Sato T Ohmura F Hata K Yamaguchi K Hirata N Sato 2005 A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins Clin Cancer Res 11 4 1474 1482 10.1158/1078-0432.CCR-03-0817 1:CAS:528:DC%2BD2MXhvVSrsbw%3D 15746049 (Pubitemid 40315229)
23. M Frost J Newell MA Lones SR Tripp MS Cairo SL Perkins 2004 Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and diffuse large B-cell lymphoma Am J Clin Pathol 121 3 384 392 10.1309/8WYNVUTGV9RPHUQH 15023043
24. M Sugimoto H Tahara T Ide Y Furuichi 2004 Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus Cancer Res 64 10 3361 3364 10.1158/0008-5472.CAN-04-0079 1:CAS:528:DC%2BD2cXktVWhsrY%3D 15150084 (Pubitemid 38657904)
25. N Melo E Matutes I Cordone R Morilla D Catovsky 1992 Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders J Clin Pathol 45 660 663 10.1136/jcp.45.8.660 1401173
26. MP Oyarzo E Drakos C Atwell HM Amin LJ Medeiros GZ Rassidakis 2006 Intrinsic apoptotic pathway in anaplastic large cell lymphoma Hum Pathol 37 7 874 882 10.1016/j.humpath.2006.02.020 1:CAS:528:DC%2BD28XlvFGmsLg%3D 16784988 (Pubitemid 43902949)
27. WL Zhao ME Daneshpouy N Mounier J Briere C Leboeuf LF Plassa E Turpin JM Cayuela JC Ameisen C Gisselbrecht A Janin 2004 Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma Blood 103 2 695 697 10.1182/blood-2003-06-1901 1:CAS:528:DC%2BD2cXmsFCgsQ%3D%3D 12969962 (Pubitemid 38140106)
28. GZ Rassidakis D Jones R Lai P Ramalingam AH Sarris TJ McDonnell LJ Medeiros 2003 BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation J Pathol. 200 2 240 248 10.1002/path.1346 1:CAS:528:DC%2BD3sXlsFeisrc%3D 12754745 (Pubitemid 36748033)
29. GZ Rassidakis AH Sarris M Herling RJ Ford F Cabanillas TJ McDonnell LJ Medeiros 2001 Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage Am J Pathol 159 2 527 535 1:CAS:528:DC%2BD3MXms1Witr8%3D 11485911
30. R Garcia-Sanz MV Montero MG Diaz, et al. 1998 Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype Haematologica 83 3 209 216 1:CAS:528:DyaK1cXktlemsrc%3D 9573674
31. KB Pagnano J Vassallo I Lorand-Metze FF Costa ST Saad 2001 p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas Am J Hematol 67 2 84 92 10.1002/ajh.1084 1:CAS:528:DC%2BD3MXkt1OitL0%3D 11343379 (Pubitemid 32423845)
32. O Bairey Y Zimra M Shaklai E Okon E Rabizadeh 1999 Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas Clin Cancer Res 5 10 2860 2866 1:STN:280:DC%2BD3c%2FgsFOntA%3D%3D 10537354
33. S Aktaş A Kargi N Olgun G Diniz A Erbay C Vergin 2007 Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma Lymphat Res Biol 5 3 175 182 10.1089/lrb.2007.5305 18035936 (Pubitemid 350172943)
34. C Mancao W Hammerschmidt 2007 Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival Blood 110 10 3715 21 10.1182/blood-2007-05-090142 1:CAS:528:DC%2BD2sXhtlarurvK 17682125 Nov 15 (Pubitemid 350159641)
35. E Anderton J Yee P Smith T Crook RE White MJ Allday 2008 Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma Oncogene 27 4 421 433 10.1038/sj.onc.1210668 1:CAS:528:DC%2BD1cXnt1eqtA%3D%3D 17653091